A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Mannkind Corp stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 66,144 shares of MNKD stock, worth $392,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,144
Previous 66,144 -0.0%
Holding current value
$392,895
Previous $415,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$4.05 - $5.43 $48 - $65
-12 Reduced 0.02%
66,144 $345,000
Q1 2024

Apr 25, 2024

SELL
$3.25 - $5.27 $8,411 - $13,638
-2,588 Reduced 3.76%
66,156 $299,000
Q4 2023

Jan 30, 2024

BUY
$3.34 - $4.29 $23,894 - $30,690
7,154 Added 11.62%
68,744 $250,000
Q3 2023

Oct 25, 2023

BUY
$3.91 - $5.45 $58,419 - $81,428
14,941 Added 32.03%
61,590 $254,000
Q2 2023

Aug 07, 2023

SELL
$3.72 - $4.79 $3,214 - $4,138
-864 Reduced 1.82%
46,649 $189,000
Q1 2023

May 08, 2023

BUY
$3.95 - $5.63 $8,701 - $12,402
2,203 Added 4.86%
47,513 $194,000
Q4 2022

Feb 01, 2023

BUY
$3.02 - $5.37 $17,044 - $30,308
5,644 Added 14.23%
45,310 $238,000
Q2 2022

Aug 09, 2022

SELL
$2.67 - $4.77 $1,361 - $2,432
-510 Reduced 1.27%
39,666 $151,000
Q1 2022

Apr 21, 2022

SELL
$2.62 - $4.45 $25,801 - $43,823
-9,848 Reduced 19.69%
40,176 $148,000
Q4 2021

Feb 01, 2022

SELL
$4.05 - $5.37 $6,876 - $9,118
-1,698 Reduced 3.28%
50,024 $219,000
Q3 2021

Nov 15, 2021

BUY
$3.89 - $5.48 $2,547 - $3,589
655 Added 1.28%
51,722 $225,000
Q2 2021

Jul 30, 2021

BUY
$3.61 - $5.45 $122,808 - $185,403
34,019 Added 199.55%
51,067 $278,000
Q1 2021

May 03, 2021

BUY
$3.14 - $6.14 $53,530 - $104,674
17,048 New
17,048 $67,000
Q1 2018

May 03, 2018

SELL
$2.28 - $3.8 $606 - $1,010
-266 Closed
0 $0
Q4 2017

Jan 31, 2018

BUY
$2.28 - $6.71 $606 - $1,784
266
266 $1,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.53B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.